echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > JPEM: a 7-year-old boy with central diabetes insipidus was reported with thickened pituitary stalk and positive Rab3A-Ab

    JPEM: a 7-year-old boy with central diabetes insipidus was reported with thickened pituitary stalk and positive Rab3A-Ab

    • Last Update: 2023-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Highly aggressive pathologic diagnosis is necessary to differentiate central diabetes insipidus (CDI) with thickened pituitary
    stalk.
    Lymphocytic funnel-neurohypophysitis (LINH) due to autoimmune cumulative pituitary stalk is a differentiated disorder that has recently been reported positive
    for anti-rabphilin-3A antibodies (Rab3A-Ab).
    The Journal of Pediatric Endocrinology and Metabolism reported that a child with CDI combined with pituitary hormone deficiency tested positive
    for Rab3A-Ab shortly after the onset of CDI.

    Case: Patient, male, 7 years old, reported symptoms of polyuria and polydipsia for 2 months
    .
    The frequency of urination is more than 20 times a day with nocturia, the daily urine output is 4-5L, and urine sugar and hypotonic urine are negative
    .
    The results of the water deprivation test showed that the maximum urine osmolality was as low as 104 mOsm/kg, although the plasma osmolality increased to 300 mOsm/kg
    .
    After 2 hours of subcutaneous vasopressin, urine osmolality rises to 384 mOsm/kg, and CDI
    is diagnosed.
    MRI of the brain shows T1-weighted thickening of the pituitary stalk and decreased signaling of the posterior pituitary gland
    .
    Oral desmopressin therapy is initiated
    .

    Patients present with growth hormone deficiency with a slowed
    growth rate.
    Magnetic resonance imaging (MRI) of the brain shows thickening
    of the pituitary stalk.
    Placental alkaline phosphatase levels (tumor markers for germ cell tumors) in cerebrospinal fluid are lower than sensitivity levels
    .
    Eight months after the onset of CDI, Rab3A-Ab is positive, MRI shows thickened pituitary stalk shrinkage, and the diagnosis is lymphocytic infundibular panhypophysitis (LIPH).

    Autoimmunity
    has been reported in many cases of idiopathic CDI in children and young adults.
    Although several autoantibodies to the pituitary funnel have been reported to date, there are no clinically proven specific autoantibodies
    for the diagnosis of LINH.
    It has recently been reported that 4 patients with a biopsy diagnosis of LINH and 72% of patients with a clinical diagnosis of LINH tested positive
    for Rab3A-Ab.
    Rab3A-Ab positivity has high sensitivity and specificity for adult LINH and is a promising clinical marker
    .
    The presence of Rab3A-Ab in patients with CDI with thickened pituitary stalk suggests autoimmune-related CDI, including LINH
    .

    The study reported the first case
    of Rab3A-Ab-positive pediatric patients shortly after the onset of CDI.
    This case demonstrates the pathogenesis of lymphocytic hypophysitis in children
    .

    Limitations in case reporting do not exclude the possibility of other causes, including LCH and GCT, for CDI because pathologic diagnosis
    has not been made.

    In conclusion, Rab3A-Ab is a useful auxiliary diagnostic tool
    for childhood-onset lymphocytic hypophysitis.

    Original source:

    Kazutaka Morota, Hiroaki Tadokoro, et al, A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and antirabphilin-3A antibody positivity, J Pediatr Endocrinol Metab 2022, https://orcid.
    org/0000-0002-5882-661X.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.